Wockhardt’s infective drugs receive QIDP status from US FDA
WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Piramal Enterprises and Navin Fluorine International to form JV company
To develop, manufacture and sell speciality fluorochemicals with specific focus on applications in healthcare
US FDA posts draft guidance on correspondence related to GDUFA Amendments
Outlines communication process between industry and agency
SC defers hearing on clinical trials
Citing the need for a more detailed study the documents submitted by both parties, the Supreme Court postponed the hearing…
Roche and InterMune in definitive merger agreement
Will allow Roche to broaden and strengthen its respiratory portfolio globally
USP joins efforts to halt illegal online drug sales
Helping to ensure the quality, integrity, safety and benefits of medicines and foods is a core mission for USP
August 16-31, 2014
{source}<div data-configid="5690019/9025764" style="width: 600px; height: 396px;" class="issuuembed"></div><script…
Claris Lifesciences gets UK MHRA approval for plant 2
It has plans to install another line in this new plant (Plant 2)